https://www.news-medical.net/news/20221031/Study-expands-breast-cancer-patient-population-that-can-benefit-from-PARP-inhibitors.aspx
0
0
10/31/22 at 7:40pm
Organization
News-Medical.Net
40 words
0
Comments
A drug approved to treat breast cancer patients with mutations in the BRCA1 or BRCA2 genes may also benefit people who have other genetic mutations.
You are the first to view
Create an account
or login to join the discussion